Trial Profile
A single center, randomized, double-blind, placebo-controlled, single and multiple-dose study of DEB025 (alisporivir) in healthy Chinese and Caucasian subjects
Status:
Suspended
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Alisporivir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 03 Jul 2013 Status changed from not yet recruiting to suspended as reported by Clinical Research Information Service (CriS) - Republic of Korea.
- 20 Mar 2012 New trial record